LAB FY 2021 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$131M-5.5% YoY

Gross Profit

$69M53.1% margin

Operating Income

-$67M-51.7% margin

Net Income

-$59M-45.4% margin

EPS (Diluted)

$-0.78

Cash Flow

Operating Cash Flow

-$44M

Free Cash Flow

-$57M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$275M

Total Liabilities

$181M

Stockholders' Equity

$95M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$131M	$138M	-5.5%
Gross Profit	$69M	$83M	-16.7%
Operating Income	-$67M	-$51M	-32.2%
Net Income	-$59M	-$53M	-11.7%